ABT logo

Abbott Laboratories (ABT) Gross profit

Annual gross profit:

$21.32B+$1.29B(+6.43%)
December 31, 2024

Summary

  • As of today (September 12, 2025), ABT annual gross profit is $21.32 billion, with the most recent change of +$1.29 billion (+6.43%) on December 31, 2024.
  • During the last 3 years, ABT annual gross profit has fallen by -$1.89 billion (-8.14%).
  • ABT annual gross profit is now -9.03% below its all-time high of $23.44 billion, reached on December 31, 2011.

Performance

ABT Gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABTincome statement metrics

quarterly gross profit:

$5.88B+$432.00M(+7.94%)
June 30, 2025

Summary

  • As of today (September 12, 2025), ABT quarterly gross profit is $5.88 billion, with the most recent change of +$432.00 million (+7.94%) on June 30, 2025.
  • Over the past year, ABT quarterly gross profit has increased by +$571.00 million (+10.76%).
  • ABT quarterly gross profit is now -10.64% below its all-time high of $6.58 billion, reached on December 31, 2011.

Performance

ABT quarterly gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABTincome statement metrics

TTM gross profit:

$22.34B+$571.00M(+2.62%)
June 30, 2025

Summary

  • As of today (September 12, 2025), ABT TTM gross profit is $22.34 billion, with the most recent change of +$571.00 million (+2.62%) on June 30, 2025.
  • Over the past year, ABT TTM gross profit has increased by +$1.73 billion (+8.37%).
  • ABT TTM gross profit is now -8.92% below its all-time high of $24.53 billion, reached on September 30, 2012.

Performance

ABT TTM gross profit Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherABTincome statement metrics

Gross profit Formula

Gross Profit = Revenue − Cost Of Goods Sold

ABT Gross profit Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+6.4%+10.8%+8.4%
3 y3 years-8.1%+1.8%-8.5%
5 y5 years+27.8%+68.8%+40.1%

ABT Gross profit Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-8.1%+6.4%at high+22.3%-8.5%+13.1%
5 y5-year-8.1%+27.8%-7.7%+68.8%-8.5%+40.1%
alltimeall time-9.0%+2283.3%-10.6%+597.8%-8.9%+2553.4%

ABT Gross profit History

DateAnnualQuarterlyTTM
Jun 2025
-
$5.88B(+7.9%)
$22.34B(+2.6%)
Mar 2025
-
$5.44B(-2.8%)
$21.77B(+2.0%)
Dec 2024
$21.32B(+6.4%)
$5.60B(+3.2%)
$21.35B(+1.6%)
Sep 2024
-
$5.43B(+2.3%)
$21.01B(+1.9%)
Jun 2024
-
$5.30B(+5.6%)
$20.62B(+1.8%)
Mar 2024
-
$5.02B(-4.5%)
$20.26B(+1.1%)
Dec 2023
$20.04B(-10.2%)
$5.26B(+4.4%)
$20.04B(+1.5%)
Sep 2023
-
$5.03B(+1.8%)
$19.75B(-0.9%)
Jun 2023
-
$4.95B(+2.9%)
$19.93B(-4.0%)
Mar 2023
-
$4.80B(-3.3%)
$20.76B(-7.0%)
Dec 2022
$22.32B(-3.8%)
$4.97B(-4.6%)
$22.32B(-5.3%)
Sep 2022
-
$5.21B(-9.8%)
$23.56B(-3.5%)
Jun 2022
-
$5.77B(-9.3%)
$24.41B(+1.7%)
Mar 2022
-
$6.37B(+2.6%)
$24.01B(+3.4%)
Dec 2021
$23.21B(+33.6%)
$6.21B(+2.5%)
$23.21B(+2.3%)
Sep 2021
-
$6.06B(+12.7%)
$22.69B(+8.2%)
Jun 2021
-
$5.38B(-3.5%)
$20.96B(+9.9%)
Mar 2021
-
$5.57B(-2.1%)
$19.07B(+9.7%)
Dec 2020
$17.38B(+4.1%)
$5.69B(+31.3%)
$17.38B(+8.1%)
Sep 2020
-
$4.33B(+24.4%)
$16.07B(+0.8%)
Jun 2020
-
$3.48B(-10.2%)
$15.95B(-4.3%)
Mar 2020
-
$3.88B(-11.5%)
$16.67B(-0.1%)
Dec 2019
$16.69B(+5.5%)
$4.38B(+4.1%)
$16.68B(+1.8%)
Sep 2019
-
$4.21B(+0.2%)
$16.38B(+1.4%)
Jun 2019
-
$4.20B(+8.0%)
$16.16B(+1.4%)
Mar 2019
-
$3.89B(-4.7%)
$15.93B(+0.7%)
Dec 2018
$15.82B(+21.1%)
$4.08B(+2.5%)
$15.82B(+1.9%)
Sep 2018
-
$3.98B(+0.2%)
$15.52B(+3.4%)
Jun 2018
-
$3.98B(+5.2%)
$15.02B(+6.5%)
Mar 2018
-
$3.78B(-0.1%)
$14.10B(+7.7%)
Dec 2017
$13.07B(+16.2%)
$3.78B(+8.7%)
$13.09B(+7.1%)
Sep 2017
-
$3.48B(+13.7%)
$12.23B(+5.2%)
Jun 2017
-
$3.06B(+10.2%)
$11.62B(+1.5%)
Mar 2017
-
$2.77B(-4.9%)
$11.45B(+1.8%)
Dec 2016
$11.24B(+2.6%)
$2.92B(+1.6%)
$11.24B(+1.2%)
Sep 2016
-
$2.87B(-0.4%)
$11.12B(+1.1%)
Jun 2016
-
$2.88B(+12.2%)
$10.99B(+1.0%)
Mar 2016
-
$2.57B(-7.8%)
$10.89B(-0.7%)
Dec 2015
$10.96B(+4.5%)
$2.79B(+1.5%)
$10.96B(-0.5%)
Sep 2015
-
$2.75B(-1.2%)
$11.01B(+1.0%)
Jun 2015
-
$2.78B(+5.1%)
$10.91B(-0.9%)
Mar 2015
-
$2.64B(-6.9%)
$11.01B(+0.3%)
Dec 2014
$10.49B(+6.4%)
$2.84B(+7.5%)
$10.98B(+2.8%)
Sep 2014
-
$2.64B(-8.2%)
$10.68B(-0.8%)
Jun 2014
-
$2.88B(+10.1%)
$10.76B(+1.8%)
Mar 2014
-
$2.62B(+3.1%)
$10.58B(-1.2%)
Dec 2013
$9.86B(-9.2%)
$2.54B(-7.0%)
$10.70B(-2.5%)
Sep 2013
-
$2.73B(+1.4%)
$10.98B(-23.5%)
Jun 2013
-
$2.69B(-1.8%)
$14.35B(-19.3%)
Mar 2013
-
$2.74B(-2.5%)
$17.80B(-14.3%)
Dec 2012
$10.85B(-53.7%)
$2.81B(-53.9%)
$20.77B(-15.3%)
Sep 2012
-
$6.10B(-0.6%)
$24.53B(+0.8%)
Jun 2012
-
$6.14B(+7.3%)
$24.33B(+1.6%)
Mar 2012
-
$5.72B(-13.1%)
$23.96B(+2.3%)
Dec 2011
$23.44B(+13.8%)
$6.58B(+11.4%)
$23.41B(+3.0%)
Sep 2011
-
$5.90B(+2.5%)
$22.74B(+4.2%)
Jun 2011
-
$5.76B(+11.3%)
$21.83B(+2.2%)
Mar 2011
-
$5.17B(-12.4%)
$21.35B(+3.9%)
Dec 2010
$20.59B(+16.9%)
$5.90B(+18.4%)
$20.54B(+4.3%)
Sep 2010
-
$4.99B(-5.6%)
$19.68B(+3.0%)
Jun 2010
-
$5.28B(+21.1%)
$19.11B(+5.0%)
Mar 2010
-
$4.36B(-13.6%)
$18.20B(+3.3%)
Dec 2009
$17.62B(+3.4%)
$5.05B(+14.4%)
$17.62B(+1.6%)
Sep 2009
-
$4.42B(+1.1%)
$17.34B(+0.8%)
Jun 2009
-
$4.37B(+15.4%)
$17.20B(+1.0%)
Mar 2009
-
$3.78B(-20.7%)
$17.02B(-0.1%)
Dec 2008
$17.04B(+16.9%)
$4.77B(+11.7%)
$17.04B(+4.4%)
Sep 2008
-
$4.27B(+1.9%)
$16.33B(+4.9%)
Jun 2008
-
$4.19B(+10.2%)
$15.57B(+4.2%)
Mar 2008
-
$3.80B(-6.3%)
$14.94B(+4.8%)
Dec 2007
$14.59B(+13.6%)
$4.06B(+15.6%)
$14.25B(+5.2%)
Sep 2007
-
$3.51B(-1.5%)
$13.54B(+2.5%)
Jun 2007
-
$3.57B(+14.5%)
$13.21B(+3.6%)
Mar 2007
-
$3.11B(-7.1%)
$12.76B(+3.3%)
Dec 2006
$12.84B
$3.35B(+5.3%)
$12.35B(+0.9%)
Sep 2006
-
$3.18B(+2.3%)
$12.23B(+2.5%)
DateAnnualQuarterlyTTM
Jun 2006
-
$3.11B(+15.2%)
$11.93B(+1.9%)
Mar 2006
-
$2.70B(-16.5%)
$11.71B(-1.3%)
Dec 2005
$11.87B(+10.0%)
$3.24B(+12.3%)
$11.87B(+1.8%)
Sep 2005
-
$2.88B(-0.4%)
$11.66B(+2.8%)
Jun 2005
-
$2.89B(+1.1%)
$11.35B(+2.3%)
Mar 2005
-
$2.86B(-5.5%)
$11.09B(+1.1%)
Dec 2004
$10.80B(+4.8%)
$3.03B(+17.9%)
$10.96B(+0.6%)
Sep 2004
-
$2.57B(-2.6%)
$10.90B(+0.6%)
Jun 2004
-
$2.63B(-3.7%)
$10.83B(+1.6%)
Mar 2004
-
$2.74B(-7.6%)
$10.66B(+3.4%)
Dec 2003
$10.30B(+10.7%)
$2.96B(+18.5%)
$10.30B(+3.7%)
Sep 2003
-
$2.50B(+1.6%)
$9.93B(+2.3%)
Jun 2003
-
$2.46B(+3.3%)
$9.71B(+3.3%)
Mar 2003
-
$2.38B(-8.1%)
$9.40B(+1.0%)
Dec 2002
$9.31B(+6.6%)
$2.59B(+14.0%)
$9.31B(+2.5%)
Sep 2002
-
$2.27B(+5.8%)
$9.08B(+1.5%)
Jun 2002
-
$2.15B(-6.3%)
$8.95B(-0.0%)
Mar 2002
-
$2.29B(-3.0%)
$8.95B(+4.4%)
Dec 2001
$8.73B(+16.3%)
$2.36B(+10.5%)
$8.57B(+4.3%)
Sep 2001
-
$2.14B(-0.5%)
$8.22B(+4.3%)
Jun 2001
-
$2.15B(+12.3%)
$7.88B(+4.1%)
Mar 2001
-
$1.92B(-4.6%)
$7.57B(+0.8%)
Dec 2000
$7.51B(+4.3%)
$2.01B(+11.4%)
$7.51B(+0.4%)
Sep 2000
-
$1.80B(-2.0%)
$7.48B(+3.7%)
Jun 2000
-
$1.84B(-0.9%)
$7.21B(+0.1%)
Mar 2000
-
$1.86B(-6.3%)
$7.21B(+0.1%)
Dec 1999
$7.20B(+1.7%)
$1.98B(+29.0%)
$7.20B(+1.3%)
Sep 1999
-
$1.54B(-16.2%)
$7.11B(-1.7%)
Jun 1999
-
$1.83B(-1.0%)
$7.23B(+0.9%)
Mar 1999
-
$1.85B(-2.0%)
$7.17B(+1.2%)
Dec 1998
$7.08B(+3.6%)
$1.89B(+13.7%)
$7.08B(+0.4%)
Sep 1998
-
$1.66B(-6.1%)
$7.05B(+0.5%)
Jun 1998
-
$1.77B(+0.2%)
$7.02B(+1.2%)
Mar 1998
-
$1.76B(-5.0%)
$6.93B(+1.4%)
Dec 1997
$6.84B(+8.9%)
$1.86B(+14.5%)
$6.84B(+1.7%)
Sep 1997
-
$1.62B(-3.6%)
$6.72B(+2.4%)
Jun 1997
-
$1.68B(+0.7%)
$6.57B(+2.0%)
Mar 1997
-
$1.67B(-3.9%)
$6.44B(+2.5%)
Dec 1996
$6.28B(+10.5%)
$1.74B(+18.5%)
$6.28B(+3.7%)
Sep 1996
-
$1.47B(-5.6%)
$6.06B(+2.5%)
Jun 1996
-
$1.56B(+2.6%)
$5.91B(+2.4%)
Mar 1996
-
$1.52B(-0.0%)
$5.77B(+1.4%)
Dec 1995
$5.69B(+10.2%)
$1.52B(+14.8%)
$5.69B(+1.8%)
Sep 1995
-
$1.32B(-6.6%)
$5.59B(+1.5%)
Jun 1995
-
$1.41B(-1.5%)
$5.50B(+2.9%)
Mar 1995
-
$1.44B(+1.4%)
$5.35B(+3.6%)
Dec 1994
$5.16B(+9.3%)
$1.42B(+14.2%)
$5.16B(+11.0%)
Sep 1994
-
$1.24B(-1.4%)
$4.65B(-0.6%)
Jun 1994
-
$1.26B(+0.5%)
$4.68B(-1.3%)
Mar 1994
-
$1.25B(+38.3%)
$4.74B(+0.4%)
Dec 1993
$4.72B(+8.7%)
$904.32M(-28.7%)
$4.72B(-7.5%)
Sep 1993
-
$1.27B(-3.9%)
$5.11B(+1.6%)
Jun 1993
-
$1.32B(+7.1%)
$5.03B(+3.4%)
Mar 1993
-
$1.23B(-4.4%)
$4.86B(+1.8%)
Dec 1992
$4.35B(+16.3%)
$1.29B(+8.5%)
$4.77B(+3.1%)
Sep 1992
-
$1.19B(+3.0%)
$4.63B(+4.7%)
Jun 1992
-
$1.15B(+0.6%)
$4.42B(+3.5%)
Mar 1992
-
$1.15B(+0.2%)
$4.28B(+3.9%)
Dec 1991
$3.74B(+15.0%)
$1.14B(+16.7%)
$4.12B(+3.7%)
Sep 1991
-
$980.90M(-2.3%)
$3.97B(+2.9%)
Jun 1991
-
$1.00B(+1.7%)
$3.86B(+2.9%)
Mar 1991
-
$986.70M(-1.0%)
$3.75B(+4.0%)
Dec 1990
$3.25B(+15.1%)
$996.90M(+14.6%)
$3.60B(+38.2%)
Sep 1990
-
$869.70M(-2.9%)
$2.61B(+50.0%)
Jun 1990
-
$895.90M(+6.4%)
$1.74B(+106.4%)
Mar 1990
-
$842.10M
$842.10M
Dec 1989
$2.82B(+9.3%)
-
-
Dec 1988
$2.58B(+13.0%)
-
-
Dec 1987
$2.29B(+17.9%)
-
-
Dec 1986
$1.94B(+16.4%)
-
-
Dec 1985
$1.67B(+8.2%)
-
-
Dec 1984
$1.54B(+9.1%)
-
-
Dec 1983
$1.41B(+19.3%)
-
-
Dec 1982
$1.18B(+13.3%)
-
-
Dec 1981
$1.04B(+16.6%)
-
-
Dec 1980
$894.76M
-
-

FAQ

  • What is Abbott Laboratories annual gross profit?
  • What is the all time high annual gross profit for Abbott Laboratories?
  • What is Abbott Laboratories annual gross profit year-on-year change?
  • What is Abbott Laboratories quarterly gross profit?
  • What is the all time high quarterly gross profit for Abbott Laboratories?
  • What is Abbott Laboratories quarterly gross profit year-on-year change?
  • What is Abbott Laboratories TTM gross profit?
  • What is the all time high TTM gross profit for Abbott Laboratories?
  • What is Abbott Laboratories TTM gross profit year-on-year change?

What is Abbott Laboratories annual gross profit?

The current annual gross profit of ABT is $21.32B

What is the all time high annual gross profit for Abbott Laboratories?

Abbott Laboratories all-time high annual gross profit is $23.44B

What is Abbott Laboratories annual gross profit year-on-year change?

Over the past year, ABT annual gross profit has changed by +$1.29B (+6.43%)

What is Abbott Laboratories quarterly gross profit?

The current quarterly gross profit of ABT is $5.88B

What is the all time high quarterly gross profit for Abbott Laboratories?

Abbott Laboratories all-time high quarterly gross profit is $6.58B

What is Abbott Laboratories quarterly gross profit year-on-year change?

Over the past year, ABT quarterly gross profit has changed by +$571.00M (+10.76%)

What is Abbott Laboratories TTM gross profit?

The current TTM gross profit of ABT is $22.34B

What is the all time high TTM gross profit for Abbott Laboratories?

Abbott Laboratories all-time high TTM gross profit is $24.53B

What is Abbott Laboratories TTM gross profit year-on-year change?

Over the past year, ABT TTM gross profit has changed by +$1.73B (+8.37%)
On this page